The United States designated Anthropic a national security supply chain risk in February. The British government designated it a candidate for a dual London stock listing roughly six weeks later.
That contrast is the real story in Anthropic's expanding British footprint. While Washington barred its own defense agencies from using Claude for autonomous weapons and mass domestic surveillance — and a federal judge temporarily blocked that blacklisting pending litigation — London saw something different in Anthropic's refusal: not a liability, but a selling point.
Britain has been quietly preparing the pitch longer than the headlines suggest. The UK Department for Science, Innovation and Technology signed a memorandum of understanding with Anthropic in February 2025, a full year before the Pentagon clash, covering AI safety research collaboration, public sector deployment, and what the document calls "situational awareness" — using Anthropic's Economic Index to inform UK AI policy. The MOU was signed by Peter Kyle, Britain's science secretary, and Anthropic CEO Dario Amodei. It was not classified, announced with fanfare, or particularly noticed at the time.
It is noticed now. Government officials backed by Prime Minister Keir Starmer's office have since sketched proposals for Anthropic ranging from a deeper London office presence to a dual listing on the London Stock Exchange, according to the Financial Times, which first reported the courtship. An official described the dual listing as "the dream" — while also calling it unlikely. Amodei is expected to hear the pitch in person during a UK visit in late May.
The UK's interest is not Anthropic's size alone. It is that Anthropic's growth is visibly attached to a set of constraints the US government found intolerable. Claude paid subscriptions have more than doubled since January, according to figures Anthropic confirmed to TechCrunch, driven by record new subscriber sign-ups in January and February — precisely when the Pentagon dispute was escalating publicly. Third-party analysis of 28 million US consumer credit card transactions, conducted by Indagari for TechCrunch, corroborated the surge. Anthropic's annualized revenue has climbed from roughly $9 billion at the end of 2025 to more than $30 billion today, according to Quartz. The standoff was free advertising.
What the UK appears to be calculating is that a company whose safety commitments are this publicly durable — this expensive, in Washington — is also a company that British regulators and public institutions can actually work with. The MOU already covers deploying Claude in citizen-facing government services. The new proposals would go further, embedding Anthropic in the UK's AI industrial base at a moment when the country's AI Opportunities Action Plan is trying to position Britain as a global hub.
There is a counterargument, and it is being argued in a federal courtroom. Anthropic's refusal to allow unrestricted military access to its models represents, in the Department of Defense's view, a supply chain vulnerability the US cannot accept. A judge blocked the designation in March; a second Anthropic lawsuit over the underlying supply chain risk designation is still pending. The Pentagon is appealing. If the US courts ultimately uphold the blacklisting, Britain's recruiting pitch becomes considerably more complicated — a company the UK is courting as a partner would simultaneously be one Washington has formally designated a security risk.
Anthropic declined to comment on the specifics of the UK proposals. The company has said it will continue serving US national security customers where its red lines are not crossed, and is proud of work already done with the Department of Defense on intelligence analysis, modeling, and operational planning.
For now, London has the edge. The UK's existing MOU with Anthropic predates the Pentagon clash by twelve months — which means either the British government was unusually prescient, or it was already building a relationship that the US dispute has since made dramatically more visible. Amodei's May visit will be the test: whether a conversation designed in the abstract becomes a concrete commitment in the shadow of a transatlantic regulatory rupture.
A company fighting the American government in two courts is not a normal candidate for a London listing. That the UK is still interested is itself a signal.